Chardan Capital Markets Starts Novavax (NVAX) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.13 -2.87%
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 16 | New: 16
Rating Summary:
10 Buy, 3 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 16 | New: 16
Join SI Premium – FREE
Chardan Capital Markets initiated coverage on Novavax (NASDAQ: NVAX) with a Neutral rating and a price target of $5.75.
For an analyst ratings summary and ratings history on Novavax click here. For more ratings news on Novavax click here.
Shares of Novavax closed at $5.49 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novavax (NVAX) Reiterated at Overweight by Cantor Fitzgerald
- JPMorgan Assumes Airtac International (1590:TT) at Overweight
- Truist Securities Starts PPL Corp (PPL) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Chardan Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
